OMB.report

Federal forms, ICRs, and supporting documents

Information Collection Request

Form 8942 - Application for Certification of Qualified Investments Eligible for Credits; Notice 2010-45 - Qualifying Therapeutic Discovery Project Credit

ICR 201310-1545-002 · OMB 1545-2175 · Historical Active

Forms and Documents
DocumentTypeStatusAvailability
Form QTDP Notice 2010-45- Qualifying Therapeutic Discovery Project Credit Form Unchanged Available
Form 8942 Form 8942 - Application for Certification of Qualified Investments Eligible for Credits Form Modified Available
1545-2175_supporting_statement2014[1].doc Supporting Statement A Uploaded 2014-01-31 Available
Notice 2010-45.pdf Supplementary Document Uploaded 2010-10-26 Available
IC Document Collections
IC IDCollectionTypeStatusForm
192924 Notice 2010-45- Qualifying Therapeutic Discovery Project Credit Form Unchanged
192923 Form 8942 - Application for Certification of Qualified Investments Eligible for Credits Form Modified
ICR Details
1545-2175 201310-1545-002
Historical Active 201010-1545-037
TREAS/IRS lvd-1545-002
Form 8942 - Application for Certification of Qualified Investments Eligible for Credits; Notice 2010-45 - Qualifying Therapeutic Discovery Project Credit
Extension without change of a currently approved collection   No
Regular
Approved without change 04/16/2014
Retrieve Notice of Action (NOA) 01/31/2014
  Inventory as of this Action Requested Previously Approved
04/30/2017 36 Months From Approved 04/30/2014
1,201 0 1,201
14,545 0 14,545
0 0 0
On March 23, 2010, the President signed the Patient Protection and Affordable Care Act (Act) (Pub. L. 111-148). Section 9023(a) of the Act adds section 48D to the Internal Revenue Code. Section 48D provides a 50-percent nonrefundable investment tax credit, and corresponding grant in lieu of a tax credit, for qualified investments in qualifying therapeutic discovery projects. The credit and grant are designed to encourage investments in new therapies relating to diseases. Form 8942 will be used to apply for certification and credit.
US Code: 26 USC 48D Name of Law: Qualifying Therapeutic Discovery Project Credit
   PL: Pub.L. 111 - 148 9023(a) Name of Law: Patient Protection & Affordable Care Act of 2010
  
None
Not associated with rulemaking
  78 FR 46414 07/31/2013
79 FR 5522 01/31/2014
No
  Total Approved Previously Approved Change Due to New Statute Change Due to Agency Discretion Change Due to Adjustment in Estimate Change Due to Potential Violation of the PRA
Annual Number of Responses 1,201 1,201 0 0 0 0
Annual Time Burden (Hours) 14,545 14,545 0 0 0 0
Annual Cost Burden (Dollars) 0 0 0 0 0 0
No
No
$50,000
No
No
Yes
No
No
Uncollected
B McDade 202 283-4948
  No
On behalf of this Federal agency, I certify that the collection of information encompassed by this request complies with 5 CFR 1320.9 and the related provisions of 5 CFR 1320.8(b)(3).
The following is a summary of the topics, regarding the proposed collection of information, that the certification covers:
 
 
 
 
 
 
 
    (i) Why the information is being collected;
    (ii) Use of information;
    (iii) Burden estimate;
    (iv) Nature of response (voluntary, required for a benefit, or mandatory);
    (v) Nature and extent of confidentiality; and
    (vi) Need to display currently valid OMB control number;
 
 
 
If you are unable to certify compliance with any of these provisions, identify the item by leaving the box unchecked and explain the reason in the Supporting Statement.
01/31/2014